ArticleCell death & disease2026

RILPL2 suppresses metabolic reprogramming and progression of cervical cancer by attenuating LDHA protein stability and inhibiting H3K18 lactylation.

Yujing Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.